Page 2 - Drug Manufacturers

India considers blue strips for antimicrobials to combat drug misuse

Antimicrobial resistance (AMR) occurs when bacteria and other pathogens develop resistance to antibiotics or other drugs, rendering these medicines ineffective when needed most

Abbott India Q1 results: PAT rises 13% to Rs 328 cr, income at Rs 1,625 cr

Drug firm Abbott India on Wednesday said its net profit increased by 13 per cent year on year to Rs 328 crore for the first quarter ended June 30, 2024. The company reported a net profit of Rs 290 crore in the April-June quarter of last fiscal. Total income rose to Rs 1,625 crore for the period under review as against Rs 1,535 crore in the June quarter of FY24, Abbott India said in a regulatory filing. Shares of the company on Wednesday ended 1.29 per cent up at Rs 28,159.95 apiece on the BSE.

Govt plans regulatory crackdown on similar-sounding, look-alike drug brands

Drug manufacturers in India will soon be required to upload their product formulations and brand names on the government's portal

AstraZeneca raises sales and profit forecast as demand for therapies grows

AstraZeneca's drug pipeline has evolved significantly under CEO Pascal Soriot since he took over more than a decade ago

Centre fails to form policy on online sale of drugs ahead of HC deadline

The Delhi HC had in March this year, given the government a final opportunity to frame a policy within four months, failing which, the court had stated it would hear the matter on merits

Govt planning regulatory crackdown on look-alike, sound-alike drug names

In order to safeguard patients, the Drug Technical Advisory Board (DTAB) proposed banning the production and marketing of distinct drugs under identical brand names

Medical device bodies welcome CDSCO order on self-reporting adverse effects

The drug regulator stated that medical device manufacturers need to take appropriate action for timely reporting of adverse events related to medical devices to MvPI

Former prez of Honduras convicted in US of aiding drug traffickers

Former Honduran President Juan Orlando Hernndez was convicted on Friday in New York of charges that he conspired with drug traffickers and used his military and national police force to enable tons of cocaine to make it unhindered into the United States. The jury returned its verdict at a federal court after a two week trial, which has been closely followed in his home country. Hernndez, 55, served two terms as the leader of the Central American nation of roughly 10 million people. He was arrested at his home in Tegucigalpa, the Honduran capital, three months after leaving office in 2022 and was extradited to the US in April of that year. US prosecutors accused Hernndez of working with drug traffickers as long ago as 2004, saying he took millions of dollars in bribes as he rose from rural congressman to president of the National Congress and then to the country's highest office. Hernndez acknowledged in trial testimony that drug money was paid to virtually all political parties in

Strides Pharma receives USFDA approval for neurology medication Gabapentin

Gabapentin is widely used in managing neuropathic pain associated with diabetic neuropathy, postherpetic neuralgia, and central pain

Medical groups raise concerns around India-EFTA after leaked documents

Doctors Without Borders (MSF), Public Eye, and Delhi Network of Positive People expressed concern that the deal, which is nearing completion, includes harmful intellectual property (IP) proposals

Glenmark Pharma Q3 results: Standalone loss at Rs 20 cr, revenue dips 38.4%

Glenmark is going through a transitionary phase on account of divestment of Glenmark Life Sciences, says MD

Budget to boost healthcare sector, bolster bulk drug manufacturing: Expert

India's interim Budget would help in addressing some of the major challenges being faced by the country in the health and pharma sector and reinforce India's standing as the Pharmacy of the World, a well-known pharma industry association head has said. The Union Health Ministry has been allocated Rs 90,658.63 crore in the interim Budget for 2024-2025, a hike of 12.59 per cent over 80,517.62 crore in the Budget (revised estimates) for 2023-2024. Finance Minister Nirmala Sitharaman said the government plans to set up more medical colleges by utilising existing hospital infrastructure and will form a committee to examine the issues and make relevant recommendations. India's commitment to promoting research and development in the life sciences sector will receive a boost with the government's plan to establish more medical colleges in the country, Karun Rishi, president of the USA India Chamber of Commerce said on Thursday. "This initiative will improve healthcare services and contribu

Cipla's net profit jumps 32% to Rs 1,055.9 crore in third quarter

Cipla advanced its board meeting to January 22 to approve its results for the quarter and nine months ended December 31, 2023, to avoid confusion following an alleged social media leak

Doctors should be careful of mefenamic acid's effects: Meftal makers

In the backdrop of a caution by the Indian Pharmacopoeia Commission (IPC) against mefenamic acid, a major component of painkiller meftal, the medicine's manufacturer on Tuesday said the alert seeks to advise doctors and patients to monitor the possibility of an adverse reaction of the drug. "The alert issued by IPC was to advise doctors and patients to monitor the possibility of an adverse drug reaction of mefenamic acid, which does not in any way impact the safety, efficacy and high quality of the brands that are established and supported by clinical studies," Blue Cross Laboratories, which makes meftal and meftal-spas, said in a statement. The IPC on November 30 had issued an alert on mefenamic acid stating that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome. "Healthcare professionals, patients/consumers are advised to closely monitor th

Another drug from hospitals found to be of sub-standard quality: Delhi LG

Days after Delhi Lt Governor V K Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious. Saxena had last week recommended a CBI inquiry into the alleged supply of drugs that "failed quality standard tests" and have the "potential of endangering lives." According to officials, another drug sample taken from Delhi government hospitals was failed by the RDTL, or Regional Drug Testing Laboratory, in Chandigarh. This time an anti-epilepsy drug called 'Sodium Valproate' was found to be falling short of the standards. The report was issued by a government analyst on December 22, an official said. The drugs that have been found to be of "sub-standard quality" included Cephalexin, a critical life-saving antibiotic used for the treatment of lung and urinary tract infections, according to officials. They also included Dexamethasone, a ste

Taliban sending Afghan women to prison for protection, says UN report

Taliban officials are sending Afghan women to prison to protect them from gender-based violence, according to a UN report published Thursday. Before the Taliban seized power in 2021, there were 23 state-sponsored women protection centers in Afghanistan where survivors of gender-based violence could seek refuge. Now there are none, the UN report said. Officials from the Taliban-led administration told the U.N. Assistance Mission in Afghanistan that there was no need for such shelters or that they were a Western concept. The Taliban sends women to prison if they have no male relatives to stay with or if the male relatives are considered unsafe, the report said. Authorities have also asked male relatives for commitments or sworn statements that they will not harm a female relative, inviting local elders to witness the guarantee, it added. Women are sent to prison for their protection akin to how prisons have been used to accommodate drug addicts and homeless people in Kabul, the repor

Johnson & Johnson sees 2024 sales growth slowing as top drug faces rivals

The pharma and medical devices giant will soon lose its exclusivity with psoriasis treatment Stelara, which accounted for a fifth of its drug sales in the third quarter

Pharma exports may return to double digit-growth rate: Pharmexcil

Bhaskar said while exports to North America were up 8.85 per cent during April-October, those to the US increased 9.58 per cent

Drug manufacturers in India benefit from Big Pharma interest beyond China

China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there

Strides Pharma gets USFDA approval for Levetiracetam Oral Solution

The Levetiracetam Oral Solution has a market size of around $55 million, according to data reported by IQVIA